Create your account — members get 10% off their first order
All products

Growth-Hormone Secretagogues

GHRH analogues and secretagogues, including CJC-1295, Ipamorelin and Tesamorelin.

18+ · Research use only WA dispatch

Find a product.

3 products

Browse categoriesGH secretagogues
  • Research blend Lazarus Labs CJC-1295 NO DAC + IPAMORELIN 10 MG product vial.
    GH secretagogues

    CJC-1295 No DAC + Ipamorelin 10MG

    Lazarus Labs CJC-1295 No DAC + Ipamorelin 10MG is a premium lyophilised vial with ≥99% purity and third-party COA support.Dispatched from Western Australia within 24 hours. Free express shipping over $300 with AusPost tracking.

    In stock
    Per vial $132.00 incl. GST
    View Add to cart
  • Recovery research Lazarus Labs IPAMORELIN 10 MG product vial.
    GH secretagogues

    IPAMORELIN 10MG

    Lazarus Labs IPAMORELIN 10MG is a premium lyophilised vial formulated for ghrelin receptor and growth hormone secretagogue research, with ≥99% purity and third-party COA support.Dispatched from Western Australia within 24 hours. Free express shipping over $300 with AusPost tracking.

    In stock
    Per vial $75.00 incl. GST
    View Add to cart
  • Metabolic research Lazarus Labs TESAMORELIN 10 MG product vial.
    GH secretagogues

    Tesamorelin 10MG

    Lazarus Labs Tesamorelin 10MG is a premium lyophilised vial with ≥99% purity and third-party COA support.Dispatched from Western Australia within 24 hours. Free express shipping over $300 with AusPost tracking.

    In stock
    Per vial $132.00 incl. GST
    View Add to cart
Category overviewAbout this collection

Growth-hormone secretagogues are peptides studied for their interaction with the growth-hormone / IGF-1 axis. This category includes GHRH (growth-hormone-releasing-hormone) analogues such as CJC-1295 and Tesamorelin, and the selective secretagogue Ipamorelin. Supplied as reference materials for laboratory research into endocrine signalling pathways; 99%+ purity; batch COA; ships from Western Australia.

How GHRH analogues and secretagogues are studied. This class is characterised in endocrine research through receptor pharmacology at the GHRH receptor and the ghrelin (GHS-R1a) receptor, pulsatility studies of the growth-hormone / IGF-1 axis in animal models, and analogue-stability work — for example the drug-affinity-complex (DAC) versus No-DAC variants of CJC-1295. Tesamorelin is a stabilised GHRH analogue with an extensive published record; Ipamorelin is a selective ghrelin-receptor agonist first characterised in 1998.

Where to start in this category. The overviews What is Tesamorelin? and What is CJC-1295 + Ipamorelin? cover classification, receptor-mechanism research and the primary sources. Every vial is independently tested with a published batch Certificate of Analysis.